For how we live.
A 740,744-child natural experiment tested a decade-old hypothesis that rotavirus vaccine might prevent type 1 diabetes. It found no protective effect — and no evidence of harm either.
Emulating a trial inside Veterans Health Administration records, researchers estimated adjusted mortality risk ratios of 0.90 to 0.84 for starting continuous glucose monitoring in older-onset type 1 diabetes.
Gene-edited islet cells implanted in a person's forearm are still functioning more than a year later. It is a single case report, and will need many more patients to mean anything.
PHARMAC's October 2024 decision left one brand's sensors unfunded, forcing a device switch. A single-centre audit of 79 children found HbA1c fell slightly — and cannot say the switch caused it.
A 230-patient survey from one US diabetes center found symptomatic hypoglycemia more than twice as common with adjunctive tirzepatide as with semaglutide, though GI side effects were similar between the two.
The ADA's 2026 Standards of Care add guidance on individualising obesity-drug dosing, name two eating patterns for type 2 diabetes prevention, and recommend continuous glucose monitoring from diagnosis.
The CHMP's November meeting produced ten positive opinions. Two of them — teplizumab and a Telethon-sponsored gene therapy — address conditions the EU has had no authorised treatment for.
The 27 recommendations cover monitoring, diet and medication for type 1, type 2 and gestational diabetes. WHO had guidance on diabetes and guidance on pregnancy, but never on the two together.